GlassScriptPhysician profile
Shachi Patel
NPI 1285994582
$26,728.46
in general payments reported to CMS, 2019-2025
16 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,971 · 2020: $17K · 2021: $2,900 · 2022: $3,090 · 2023: $430 · 2024: $641 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,246.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24,181.26 | 2019-2025 | Octrode, Proclaim, Eterna |
| Vertiflex, INC. | $1,204.94 | 2019 | |
| Nevro Corp. | $471.26 | 2019-2024 | Senza |
| Vertos Medical, INC. | $213.93 | 2020-2024 | Mild Device Kit |
| Averitas Pharma INC. | $163.81 | 2023-2024 | Qutenza |
| Medtronic, INC. | $83.17 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Scilex Pharmaceuticals INC. | $80.05 | 2022-2024 | Ztlido |
| Boston Scientific Corporation | $70.16 | 2025 | Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $58.27 | 2020 | |
| Octapharma USA, INC. | $45.32 | 2020 | |
| Nalu Medical, INC. | $36.40 | 2023 | Nalu Neurostimulation System |
| Mml US, INC. | $29.41 | 2025 | Reactiv8 |
| Fidia Pharma USA INC. | $29.13 | 2022-2024 | Hyalgan, Hymovis, Triluron |
| Pacira Therapeutics, INC. | $23.10 | 2019 | |
| Ibsa Pharma INC. | $20.82 | 2024 | Tirosint, Licart |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $17.43 | 2023 | Belbuca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shachi Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.